![Pascal Birman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Pascal Birman is currently the Chief Medical Officer at PHAXIAM Therapeutics SA since 2023.
Prior to this, he worked as the Medical Director at Pherecydes Pharma SA and as the Deputy Chief Medical Officer at Genfit SA.
Aktive Positionen von Pascal Birman
| Unternehmen | Position | Beginn |
|---|---|---|
| PHAXIAM THERAPEUTICS S.A. | Technik-/Wissenschafts-/F&E-Leiter | 23.06.2023 |
Ehemalige bekannte Positionen von Pascal Birman
| Unternehmen | Position | Ende |
|---|---|---|
| GENFIT | Corporate Officer/Principal | - |
| PHERECYDES PHARMA | Technik-/Wissenschafts-/F&E-Leiter | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Genfit SA
 Genfit SA BiotechnologyHealth Technology Engages in research and development of medicines and diagnostic solutions | Health Technology |
Pherecydes Pharma SA
 Pherecydes Pharma SA Pharmaceuticals: MajorHealth Technology Specializes in nano technologies for pharmaceutical purposes | Health Technology |
PHAXIAM Therapeutics SA
 PHAXIAM Therapeutics SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops red blood cell-based therapeutics for severe forms of cancer & orphan diseases | Health Technology |
